Submission of Matters to a Vote of Security Holders.
On June 11, 2021, Adaptive Biotechnologies Corporation (the 'Company') held its annual meeting of shareholders (the 'Annual Meeting'). At the Annual Meeting, the Company's shareholders voted on four proposals, as described below. Each of the proposals was described in detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 23, 2021. The vote totals noted below are final voting results from the Annual Meeting.
|
1. |
The Company's shareholders elected the following three Class II director nominees, each to hold office until the 2024 annual meeting of shareholders or until his or her successor is elected and qualified, by the vote set forth below: |
|
Nominee |
Votes For |
Votes Withheld |
Broker Non-Votes |
|||
|
Michelle Griffin |
95,779,979 |
12,600,796 |
14,450,327 |
|||
|
Peter Neupert |
92,865,432 |
15,515,343 |
14,450,327 |
|||
|
Leslie Trigg |
97,812,160 |
10,568,615 |
14,450,327 |
|
2. |
The Company's shareholders approved, on a non-binding advisory basis, the 2020 compensation of its named executive officers as described in the proxy statement based on the following results: |
|
Votes For |
Votes Against |
Abstentions |
Broker Non-Votes |
|||
|
100,345,226 |
7,888,977 |
146,572 |
14,450,327 |
|
3. |
The Company's shareholders approved, on a non-binding advisory basis, a frequency of one year for future advisory votes on named executive officers' compensation. After considering these results, we will hold a non-binding advisory vote on executive compensation on an annual basis until the next advisory vote on the frequency of non-binding votes on executive compensation. |
|
One Year |
Two Years |
Three Years |
Abstentions |
Broker Non-Votes |
||||
|
107,470,826 |
18,789 |
870,697 |
20,461 |
14,450,327 |
|
4. |
The Company's shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021 by the vote set forth below: |
|
Votes For |
Votes Against |
Abstentions |
||
|
122,794,811 |
21,326 |
14,964 |
Attachments
Disclaimer
Adaptive Biotechnologies Corporation published this content on 14 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2021 20:25:37 UTC.